InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
7
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Hickey Benjamin, Executive. Officer active across 2 companies, notably Mirati Therapeutics, Inc.. In total, 17 disclosures have been logged. Split: 0 buy · 7 sells. Total volume traded: €647k. Activity tracked since 7 January 2022. The latest transaction was filed on 27 February 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Hickey Benjamin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
3,286 shares0Common Stock, $0.10 par valueSEC:0001753055-26-000004:0
10,079 shares0Common Stock, $0.10 par valueSEC:0001753055-26-000002:0
97.391 shares@ US$38.01100.0% of flowCommon Stock, $0.10 par valueSEC:0000014272-25-000097:0
3,286 shares0Common Stock, $0.10 par valueSEC:0000014272-25-000045:0
10,078 shares0Common Stock, $0.10 par valueSEC:0000014272-25-000014:0
27,801 sharesCommon StockSEC:0001140361-24-003531:0
966 shares@ US$59.022.1% of flowCommon StockSEC:0001628280-24-001696:0
2,090 shares@ US$58.924.4% of flowCommon StockSEC:0001628280-24-000977:0
17,021 shares@ US$58.7535.6% of flowCommon StockSEC:0001628280-24-000290:0
2,220 shares@ US$56.674.6% of flowCommon StockSEC:0001628280-23-041610:0
22,297 shares@ US$37.0029.6% of flowCommon StockSEC:0001628280-23-028881:0
36,394 shares0Common StockSEC:0001214659-23-001045:0
947 shares@ US$42.37791.5% of flowCommon StockSEC:0001214659-23-000808:0
2,088 shares@ US$45.373.5% of flowCommon StockSEC:0001214659-23-000466:0
19,149 shares0Common StockSEC:0001214659-22-015199:0
10,755 shares0Common StockSEC:0001214659-22-000855:0
1,964 shares@ US$135.938950.0% of flowCommon StockSEC:0001214659-22-000471:0
17 of 17 declarations
About Hickey Benjamin
Benjamin Hickey is EVP and Chief Commercial Officer at Mirati Therapeutics, Inc. In this role, he is responsible for the company's commercial strategy and business development. His experience in the biopharmaceutical sector enables him to lead initiatives aimed at strengthening the company's market position.
